Prolonged oral contraceptive therapy in a woman with an antithrombin III abnormality involving heparin binding (type IIc) without thromboembolic complications

Blood Coagul Fibrinolysis. 1994 Apr;5(2):313-4. doi: 10.1097/00001721-199404000-00023.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antithrombin III / genetics*
  • Antithrombin III / metabolism
  • Contraceptives, Oral* / adverse effects
  • Female
  • Heparin / metabolism
  • Humans
  • Protein Binding
  • Thromboembolism / chemically induced
  • Time Factors

Substances

  • Contraceptives, Oral
  • Antithrombin III
  • Heparin